CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Silver Alginatedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00593684
NCT00593684N/ACompleted
CompareCT.gov

The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants

Baylor Research Institute·interventional·Posted Jan 15, 2008·Updated Jun 14, 2017

In Brief

A clinical study evaluating Silver Alginate for Prematurity and Very Low Birth Weight. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The purpose of this study is to test the safety of silver alginate (Algidex™) dressing in VLBW infants in preparation for a large efficacy trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrematurity, Very Low Birth Weight
CountriesUnited States
CollaboratorsDeRoyal Industries, Inc.

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 15, 2008
Enrollment StartApr 1, 2006
Primary CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 18.5 years ago

Interventions

Silver Alginatedevice

This is a sterile patch of polyurethane foam coated with silver alginate and maltodextrin matrix that is impregnated with 141 mg of ionic silver per 100 cm2.